JUNTEN BIO
Founded Year
2018Stage
Corporate Minority | AliveTotal Raised
$12.63MLast Raised
$1.85M | 4 yrs agoAbout JUNTEN BIO
JUNTEN BIO develops technologies in the field of regenerative medicine, aiming to eliminate the need for immunosuppressive agents when transplanting organs such as livers and kidneys.
Missing: JUNTEN BIO's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: JUNTEN BIO's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing JUNTEN BIO
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
JUNTEN BIO is included in 2 Expert Collections, including Regenerative Medicine.
Regenerative Medicine
1,818 items
Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
JUNTEN BIO Patents
JUNTEN BIO has filed 4 patents.
The 3 most popular patent topics include:
- Clusters of differentiation
- Immune system
- Immunology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
11/11/2019 | Immunology, Immune system, Hepatology, Clusters of differentiation, Diseases of liver | Application |
Application Date | 11/11/2019 |
|---|---|
Grant Date | |
Title | |
Related Topics | Immunology, Immune system, Hepatology, Clusters of differentiation, Diseases of liver |
Status | Application |
JUNTEN BIO Frequently Asked Questions (FAQ)
When was JUNTEN BIO founded?
JUNTEN BIO was founded in 2018.
Where is JUNTEN BIO's headquarters?
JUNTEN BIO's headquarters is located at Urbannet Nihonbashi 2-chome Building 10F, Tokyo.
What is JUNTEN BIO's latest funding round?
JUNTEN BIO's latest funding round is Corporate Minority.
How much did JUNTEN BIO raise?
JUNTEN BIO raised a total of $12.63M.
Who are the investors of JUNTEN BIO?
Investors of JUNTEN BIO include Fujifilm, H.U. Group Holdings, Daiwa Corporate Investment, Sosei CVC and Nippon Venture Capital.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.